Recent Updates
Recently added Catalysts
ABCL Positive Sentiment

AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026

Tuesday, July 7, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: AbCellera will announce its second quarter 2026 financial results on August 5, 2026. The company will also hold an earnings conference call at 2:00 p.m. Pacific Time. Investors can access a live audio webcast through the company's Investor Relations website, with a replay available afterward.
Price reaction · baseline $7.69 (2026-07-07 close) · hit after-hours · clean, no other ABCL news in the window
day 0 close
-7.7%
day 1
-5.2%
day 3 · peak
-15.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • AbCellera is set to report its financial results, indicating ongoing operations.
  • The company is focused on developing innovative antibody-based medicines.
  • The earnings call provides transparency and engagement with investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+312%
120-day peak, hindsight
Typical move
4.3%
average across 5 past catalysts
Lead asset
ABCL575
Phase 1 · Healthy Volunteers

Full Press Release Details

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) will announce its second quarter 2026 financial results on Wednesday, August 5, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.
A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website . A replay will be available through the same link following the conference call.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody-based medicines in the areas of endocrinology, women’s health, immunology, oncology, and more. For more information, please visit www.abcellera.com .
Inquiries Media: Tiffany Chiu; media@abcellera.com , +1(236)521-6774 Partnering: Murray McCutcheon, Ph.D.; partnering@abcellera.com , +1(604)559-9005 Investor Relations: Peter Ahn; ir@abcellera.com , +1(778)729-9116

Frequently Asked Questions

When will AbCellera report its Q2 2026 financial results?

AbCellera will report its Q2 2026 financial results on August 5, 2026.

What time is the earnings conference call?

The earnings conference call will be held at 2:00 p.m. Pacific Time.

How can I access the earnings conference call?

A live audio webcast of the earnings call can be accessed via AbCellera's Investor Relations website.

Will there be a replay of the earnings call?

Yes, a replay of the earnings conference call will be available through the same link.

ShareAdd on Google
Tags: ABCL AbCellera financial results Q2 2026 earnings call biotechnology
Last updated: Jul 7, 2026

Biotech snapshot

Cash runway
$540M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ABCL575Phase 1
Healthy Volunteers →

Catalyst track record

+312%
best trade around ABCL's most recent catalyst

Peak hindsight return over a 120-day window, across 5 tracked FDA/PDUFA catalysts for ABCL.

See every catalyst's timing & PoA →